Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...
The Pharmaceutical Care Management Association, which represents PBM's, called the FTC report baseless and "without ...
"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs.
UnitedHealth Group’s stock sinks after profit beat expectations but revenue missed for the first time in more than four years.